106 related articles for article (PubMed ID: 18446238)
1. High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity.
Vaitaitis GM; Wagner DH
PLoS One; 2008 Apr; 3(4):e2076. PubMed ID: 18446238
[TBL] [Abstract][Full Text] [Related]
2. T cells interact with T cells via CD40-CD154 to promote autoimmunity in type 1 diabetes.
Baker RL; Mallevaey T; Gapin L; Haskins K
Eur J Immunol; 2012 Mar; 42(3):672-80. PubMed ID: 22488364
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.
Wagner DH; Vaitaitis G; Sanderson R; Poulin M; Dobbs C; Haskins K
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3782-7. PubMed ID: 11891296
[TBL] [Abstract][Full Text] [Related]
4. CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.
Vaitaitis GM; Wagner DH
Mol Immunol; 2010 Aug; 47(14):2303-13. PubMed ID: 20646763
[TBL] [Abstract][Full Text] [Related]
5. Canine diabetes mellitus demonstrates multiple markers of chronic inflammation including Th40 cell increases and elevated systemic-immune inflammation index, consistent with autoimmune dysregulation.
Vaitaitis G; Webb T; Webb C; Sharkey C; Sharkey S; Waid D; Wagner DH
Front Immunol; 2023; 14():1319947. PubMed ID: 38318506
[TBL] [Abstract][Full Text] [Related]
6. Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS).
Curran C; Vaitaitis G; Waid D; Volmer T; Alverez E; Wagner DH
J Neuroimmunol; 2023 Jan; 374():578008. PubMed ID: 36535240
[TBL] [Abstract][Full Text] [Related]
7. The immune response of T cells and therapeutic targets related to regulating the levels of T helper cells after ischaemic stroke.
Lei TY; Ye YZ; Zhu XQ; Smerin D; Gu LJ; Xiong XX; Zhang HF; Jian ZH
J Neuroinflammation; 2021 Jan; 18(1):25. PubMed ID: 33461586
[TBL] [Abstract][Full Text] [Related]
8. Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis.
Wagner DH
Front Endocrinol (Lausanne); 2017; 8():208. PubMed ID: 28878738
[TBL] [Abstract][Full Text] [Related]
9. CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.
Vaitaitis GM; Waid DM; Yussman MG; Wagner DH
Immunology; 2017 Oct; 152(2):243-254. PubMed ID: 28542921
[TBL] [Abstract][Full Text] [Related]
10. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
Vaitaitis GM; Yussman MG; Waid DM; Wagner DH
PLoS One; 2017; 12(2):e0172037. PubMed ID: 28192476
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mechanisms involved in brain injury following cardiac arrest and cardiopulmonary resuscitation.
Xiang Y; Zhao H; Wang J; Zhang L; Liu A; Chen Y
Biomed Rep; 2016 Jul; 5(1):11-17. PubMed ID: 27330748
[TBL] [Abstract][Full Text] [Related]
12. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
Wagner DH
Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
[TBL] [Abstract][Full Text] [Related]
13. CD40 in coronary artery disease: a matter of macrophages?
Jansen MF; Hollander MR; van Royen N; Horrevoets AJ; Lutgens E
Basic Res Cardiol; 2016 Jul; 111(4):38. PubMed ID: 27146510
[TBL] [Abstract][Full Text] [Related]
14. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion.
Aloui C; Prigent A; Sut C; Tariket S; Hamzeh-Cognasse H; Pozzetto B; Richard Y; Cognasse F; Laradi S; Garraud O
Int J Mol Sci; 2014 Dec; 15(12):22342-64. PubMed ID: 25479079
[TBL] [Abstract][Full Text] [Related]
15. A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.
Vaitaitis GM; Olmstead MH; Waid DM; Carter JR; Wagner DH
Diabetologia; 2014 Nov; 57(11):2366-73. PubMed ID: 25104468
[TBL] [Abstract][Full Text] [Related]
16. Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation.
Deng G; Carter J; Traystman RJ; Wagner DH; Herson PS
J Neuroimmunol; 2014 Sep; 274(1-2):132-40. PubMed ID: 25084739
[TBL] [Abstract][Full Text] [Related]
17. Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
Waid DM; Schreiner T; Vaitaitis G; Carter JR; Corboy JR; Wagner DH
J Neuroimmunol; 2014 May; 270(1-2):75-85. PubMed ID: 24690203
[TBL] [Abstract][Full Text] [Related]
18. CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression.
Vaitaitis GM; Wagner DH
Cell Mol Immunol; 2013 Nov; 10(6):483-9. PubMed ID: 24037181
[TBL] [Abstract][Full Text] [Related]
19. An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.
Vaitaitis GM; Carter JR; Waid DM; Olmstead MH; Wagner DH
J Immunol; 2013 Jul; 191(2):717-25. PubMed ID: 23776180
[TBL] [Abstract][Full Text] [Related]
20. T cell vaccinology: exploring the known unknowns.
Burchill MA; Tamburini BA; Pennock ND; White JT; Kurche JS; Kedl RM
Vaccine; 2013 Jan; 31(2):297-305. PubMed ID: 23137843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
